Company Filing History:
Years Active: 2002-2006
Title: The Innovations of James B. Pierce
Introduction
James B. Pierce is a notable inventor based in Southbury, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of retroviral infections. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by these conditions.
Latest Patents
James B. Pierce's latest patents include a method for treating retroviral infections. This involves compositions and methods that administer a therapeutically effective amount of specific compounds to inhibit the replication of retroviruses. His second patent focuses on antiretroviral compounds and compositions, particularly certain pyridine and quinoline derivatives that inhibit the replication of HIV-1, HIV-2, and human cytomegalovirus (HCMV). These innovations are crucial in developing effective treatments for retroviral infections.
Career Highlights
James B. Pierce is associated with Uniroyal Chemical Company, Inc., where he has been able to apply his expertise in pharmaceutical development. His work has contributed to advancements in the treatment of viral infections, showcasing his commitment to improving healthcare outcomes.
Collaborations
Throughout his career, James has collaborated with notable colleagues, including John A. Lacadie and Arthur D. Brewer. These partnerships have likely enhanced the scope and impact of his research and innovations.
Conclusion
James B. Pierce's contributions to the field of pharmaceuticals, particularly in treating retroviral infections, highlight his role as an influential inventor. His patents and collaborations reflect a dedication to advancing medical science and improving patient care.